Seguridad de las vacunas que contienen timerosal: Declaración del Comité Consultivo de Inmunizaciones (CCI) de la Sociedad Chilena de Infectología
| Autor: | Alma Muñoz M, Katia Abarca V, Jorge Jiménez de la J, Vivían Luchslnger F, Miguel O'Ryan G, Erna Ripoll M, M. Teresa Valenzuela B, Rodrigo Vergara F |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
medicine.medical_specialty
Pediatrics education.field_of_study business.industry Public health Population timerosal Public Health Environmental and Occupational Health Primary health care etilmercurio Thimerosal Microbial contamination seguridad Health services Infectious Diseases Family medicine Medicine vacunas tiomersal business education Reference standards |
| Zdroj: | Revista chilena de infectología v.24 n.5 2007 SciELO Chile CONICYT Chile instacron:CONICYT |
| ISSN: | 0716-1018 |
| DOI: | 10.4067/s0716-10182007000500004 |
| Popis: | Thimerosal is a mercury derivative included in vaccines since 1930 with the aim to prevent microbial contamination. During the last decades, the use of thimerosal has been questioned, specifically because of a potential association with neurotoxicity. After a thorough review of published studies on pediatric use of thimerosal-containing vaccines, and of position papers from international expert groups, the Consultive Committee of Immunizations of the Chilean Society of Infectious Diseases concludes that there is no solid evidence of adverse events associated with the use of thimerosal containing vaccines in infants and children. Therefore, a change in current vaccine practices refererred to thimerosal-containing vaccines is not justified in Chile. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|